Table 1. Correlation between the clinicopathologic characteristics and LMO4 expression in 153 NSCLC patients.
| Factor | No. | LMO4 protein, n (%) | P | |
|---|---|---|---|---|
| Low | High | |||
| Age (years) | 0.445 | |||
| <50 | 90 | 38 (42.2) | 52 (57.8) | |
| ≥50 | 63 | 31 (48.4) | 33 (51.6) | |
| Gender | 0.101 | |||
| Male | 82 | 46 (56.1) | 36 (43.9) | |
| Female | 71 | 49 (69.0) | 22 (31.0) | |
| Tumor size (cm) | 0.012 | |||
| <3 | 55 | 25 (45.5) | 30 (54.5) | |
| ≥3 | 98 | 25 (25.5) | 73 (74.5) | |
| Smoking status | 0.092 | |||
| Smoker | 82 | 47 (57.3) | 35 (42.7) | |
| Non-smoker | 71 | 31 (43.7) | 40 (56.3) | |
| Pathology type | 0.021 | |||
| SQC | 81 | 31 (38.3) | 50 (61.7) | |
| ADC | 40 | 11 (27.5) | 29 (72.5) | |
| Other | 32 | 19 (59.4) | 13 (40.6) | |
| TNM stage | 0.000 | |||
| I–II | 41 | 29 (70.7) | 12 (29.3) | |
| III–IV | 112 | 32 (28.6) | 80 (71.4) | |
NSCLC, non-small-cell lung cancer; SQC, squamous carcinoma; ADC, adenocarcinoma.